Ryman Healthcare Limited (RYHTY)
OTCMKTS
· Delayed Price · Currency is USD
14.11
0.00 (0.00%)
Aug 29, 2024, 4:00 PM EDT
Ryman Healthcare Revenue
In the fiscal year ending March 31, 2024, Ryman Healthcare had annual revenue of 687.56M NZD with 18.22% growth. Ryman Healthcare had revenue of 365.87M in the half year ending March 31, 2024, with 40.22% growth.
Revenue
687.56M NZD
Revenue Growth
+18.22%
P/S Ratio
23.58
Revenue / Employee
89.29K NZD
Employees
7,700
Market Cap
2.08B USD
Revenue Chart
* This company reports financials in NZD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2024 | 687.56M | 105.95M | 18.22% |
| Mar 31, 2023 | 581.61M | 72.86M | 14.32% |
| Mar 31, 2022 | 508.76M | 53.07M | 11.64% |
| Mar 31, 2021 | 455.69M | 32.36M | 7.64% |
| Mar 31, 2020 | 423.34M | 41.53M | 10.88% |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
| Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sandoz Group AG | 10.11B |
| Telix Pharmaceuticals Limited | 430.80M |
| Elekta AB (publ) | 1.69B |
| Verano Holdings Corp. | 920.97M |
| Vireo Growth Inc. | 98.04M |
| Medexus Pharmaceuticals Inc. | 108.78M |
| Telescope Innovations Corp. | 2.86M |
| Zeo ScientifiX, Inc. | 4.93M |
Ryman Healthcare News
- 4 weeks ago - Ryman Healthcare bombshell: reviewing fixed weekly fees, DMF for new residents - NZ Herald
- 2 months ago - How Ryman Healthcare chairman Dean Hamilton plans to fix a financial disaster - NZ Herald